DEBIOPHARM TO PRESENT LATE BREAKING HEAD & NECK CANCER ABSTRACT AT THE 2020 EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS
One documentmore
Stories about presentation
New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety
more
Daily Preview Day 1 - IFA 2020 Special Edition
more-
PRESS RELEASE (EN/DE): Six candidates are nominated for the innovation award "Hemp Product of the Year 2020"
more ArisGlobal to Co-Present "Enhancing Operations: Enabling Digital Transformation With Next-Gen Technology" at World Drug Safety Congress Americas
moreSpectrum. The most dangerous artwork
The World's Most Dangerous Artwork / Cancer charity Deutsche Krebshilfe (German Cancer Aid), ADP, and the artistic duo LOW BROS welcomed guests to a somewhat unusual gallery opening
moreMindtree Wins SAFA Best Presented Annual Report Award
more- 5
eROCKIT meets India: Diplomatic visit to German e-Mobility Startup
more - 5
OPTIMA looks back at a successful FachPack 2019
One documentmore Abstracts highlight data on BAVENCIO as a monotherapy and in combination in multiple advanced cancers
more-
OPTIMA is breaking new ground at FachPack 2019
One documentmore -
PRESS RELEASE: Six candidates nominated for the innovation award "Hemp Product of the Year 2019"
more -
PRESS RELEASE / PRESSEMITTEILUNG: Winners of innovation award "Best CO2 Utilisation 2019"
more Merck Announces FDA Orphan Drug Designation for Bifunctional Immunotherapy M7824 in Biliary Tract Cancer
moreNew Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA® (edoxaban)
more
1